adult patients with eosinophilic esophagitis. However, a randomized placebo-controlled trial is warranted in order to verify this.
Objective: MicroRNAs (miRNAs) are endogenous, small, noncoding RNAs of 17 to 25 nucleotides that regulate approximately 30% of human genes. They are differentially expressed in various types of cancers compared with noncancerous tissues, suggesting that they may have crucial roles in tumorigenesis. The objective of this study was to discover LSCC-specific miRNAs.
Method: Global miRNA profiling (800 human miRNAs plus 10 endogenous control miRNAs) was performed on 8 formalin-fixed archival LSCC samples and 5 normal laryngeal squamous epithelium (HTG, Tucson, AZ, USA). Quantitative real-time PCR (qRT-PCR) approach was employed to verify expression status of selected miRNAs that were significantly different from normal controls.
Results: Thirty-one of the 800 human miRNAs were significantly differentially expressed (P < .05) between LSCC vs normal tissues. Selected miRNAs (miR-31, miR-193b, miR-663b, miR-923, and miR-1826) , by qRT-PCR, verified expression of consistently upregulated miR-31 and miR-193b as well as differentially expressed miR-663b, miR-923, and miR-1826. Dysregulation of miR-923 was newly observed and showed upregulation in 3 out of 8 and downregulation in 5 out of 8 LSCC.
Conclusion:
We have identified a group of 31 aberrantly expressed miRNAs in LSCC. miR-923 has not been previously reported in HNSCC, including LSCC. Further detailed examinations of this miRNA will provide opportunities to dissect the complex molecular abnormalities driving LSCC.
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Proteomic Analysis of Decellularized Tissue Engineered laryngealTracheal Scaffolds
Colin Butler (presenter); Justin Hsuan; Nick Beaumont; Sam Janes; Tahera Ansari; Martin Birchall, FRCS Objective: The clinical success of a fully tissue-engineered tracheal transplant has indicated that there may be more to using decellularized tissue as a scaffold construct. It has been hypothesized that remnant polypeptides reside in these matrices. We sought to determine the proteome profile of a decellularized laryngeal-tracheal scaffold construct.
Method: A laryngeal-tracheal construct was fabricated using standard decellularization protocols and underwent immunohistochemistry, electron microscopy, biomechanical analysis, and qPCR for total DNA content. Samples from anatomical subsites were prepared for proteomic analysis. Tandem massspectrometry (LC-MS/MS) was used to identify peptide sequences and validated using multicolor immunohistochemistry and western blotting.
Results: Decellularization of laryngea-tracheal scaffold airway construct effectively removed cells, MHC components, and DNA while maintaining similar biomechanical properties to native (nondecellularized) tissue. We identified variable expression of polypeptides in the anatomical subsites of the airway scaffold construct. A minimum core set of polypeptides was identified with a subset of proteins with putative roles beyond structural integrity. Of particular interest were small molecular weight polypeptides known to have significant roles in epithelialization and angiogenesis.
Conclusion:
We demonstrate that mass spectrometry can be used as a tool to accurately identify residual proteins in a laryngeal-tracheal scaffold. The identification of signaling proteins may be of crucial importance in designing the next generation of "intelligent" off-the-shelf scaffolds.
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Pulse Steroid Therapy inhibits Murine Subglottic Granulation Ankona Ghosh (presenter); Eugene Einhorn; Jennifer Lee, MD; Natasha Mirza, MD; Sunil Singhal, MD; Kevin Leahy, MD, PhD; Noam A. Cohen, MD, PhD
Objective: Using a functional model of airway granulation tissue in subglottic stenosis, we investigated changes in inflammatory markers within granulation tissue in response to intraperitoneal dexamethasone injections. Changes in inflammatory markers will allow us to identify potential targets for immunological therapy.
Method: Laryngotracheal complexes (LTCs) of donor mice underwent airway injury. Donor LTCs were transplanted into subcutaneous tissue of recipient mice in 2 groups: steroidtreated and untreated. The steroid-treated arm received intraperitoneal dexamethasone for 3 weeks. LTCs were then harvested. Granulation formation was measured; mRNA expression of TGF-beta and IL-1b was quantified.
Results: At 3 weeks' posttransplantation, there were statistically significant differences in observable granulation formation as well as mRNA expression of TGF-beta 1 and IL-1b in all groups within the steroid treated arm as compared to the untreated arm.
Conclusion: Systemic steroids have been used to prevent formation of granulation tissue. However, the study of immunologic markers and the corresponding changes with steroid
